MA
Mahindra Manulife Multi Cap Fund Direct Growth
Latest NAV
+10.02% 1Y
Sign In to Add to Portfolio
Benchmark: NIFTY500 Multicap 50:25:25 Total Return Index
Expense ratio
0.95%
AUM
₹7,662 Cr
Min SIP
₹500
Min lump sum
₹1,000
1Y
+10.02%
3Y (ann.)
+15.85%
5Y (ann.)
+14.93%
Launched
May 2017
Where the NAV sits & how risky it is
₹44.50
52-week range
at 68%
₹44.50
Low 23 Mar 2026₹37.63
High 28 Aug 2026₹47.75
Risk level
Very High
Low
Very high
NAV history
18 May 2017
Since inception
01 Oct 2026
Returns by period
1W
-3.35%
1M
-5.64%
3M
0.00%
6M
+15.50%
1Y
+10.02%
3Y
+15.85%
5Y
+14.93%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹500
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 95.48%
Cash & other 4.52%
Sector split
Country split
Top 5 hold 14.2%
Top 10 hold 25.1%
82 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Larsen & Toubro
INE018A01030 |
Industrials Engineering & Construction |
India |
3.23%
|
-4.49% |
| 2 | Adani Enterprises
INE423A01024 |
Energy Thermal Coal |
India |
3.16%
|
+29.87% |
| 3 | Divis Laboratories
INE361B01024 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
2.86%
|
+4.11% |
| 4 | BSE
INE118H01025 |
Financial Services Financial Data & Stock Exchanges |
India |
2.50%
|
+47.72% |
| 5 | Neuland Laboratories
INE794A01010 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
2.41%
|
+11.85% |
| 6 | Laurus Labs
INE947Q01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
2.26%
|
+25.63% |
| 7 | Polycab
INE455K01017 |
Industrials Electrical Equipment & Parts |
India |
2.19%
|
+23.01% |
| 8 | UltraTech Cement
INE481G01011 |
Basic Materials Building Materials |
India |
2.16%
|
-8.10% |
| 9 | Nippon Life India AMC
INE298J01013 |
Financial Services Asset Management |
India |
2.14%
|
+18.41% |
| 10 | Aditya Birla Capital
INE674K01013 |
Financial Services Financial Conglomerates |
India |
2.14%
|
-5.90% |
About this scheme
The investment objective of the Scheme is to provide medium to long term capital appreciation through appropriate diversification and taking low risk on business quality. The diversified portfolio would predominantly consist of equity and equity related securities including derivatives.
Fund manager(s): Neelesh Dhamnaskar, Vishal Jajoo
Exit load: Exit load of 1% if redeemed within 3 months.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
11 May 2017
Lump-sum min
₹1,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 111.5 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 23.4 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 20.6 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 20.6 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 19.2 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 19.1 pts ahead of this fund